Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Portopulmonary hypertension: Which Medications Are Safest? (32 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

32 medications are used for Portopulmonary hypertension, with 777 combined adverse event reports. The most reported drugs for Portopulmonary hypertension are AMBRISENTAN and MACITENTAN.

777
Total Reports
32
Drugs Used

All Medications for Portopulmonary hypertension Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
AMBRISENTAN AMBRISENTAN 428 10,291 32,910 11.9%
MACITENTAN OPSYNVI 153 9,886 24,183 21.8%
EPOPROSTENOL EPOPROSTENOL 52 2,713 8,838 20.4%
TREPROSTINIL TYVASO 46 8,865 35,507 9.7%
SELEXIPAG Selexipag 35 3,778 9,394 20.5%
LETAIRIS - 29 496 1,492 11.5%
SILDENAFIL Sildenafil 29 4,979 8,623 14.1%
BOSENTAN Tracleer 26 4,346 8,862 22.2%
TADALAFIL Esokalli Testosterone Booster Oral Dissolving Film 16 3,553 8,717 11.6%
BOSENTAN\BOSENTAN - 10 1,114 2,331 31.9%
VELETRI - 8 90 252 27.0%
FUROSEMIDE Furosemide 6 6,131 30,446 11.8%
OPSUMIT - 6 64 117 18.9%
NITRIC Ulspira 5 868 290 28.3%
SPIRONOLACTONE spironolactone 5 1,809 11,611 8.6%

View all 32 drugs →

Most Reported Drugs for Portopulmonary hypertension

#1 most reported
#2 most reported
#3 most reported